Dr Ryan Davis

NHMRC Early Career Fellow
Kolling Institute of Medical Research, Northern Clinical School

Telephone +61 2 9926 4868

Map

Selected grants

2012

  • Mitochondrial quality control in mitochondrial disease; Davis R; National Health and Medical Research Council (NHMRC)/Early Career Fellowships (ECF).

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Davis, R., Liang, C., Edema-Hildebrand, F., Riley, C., Needham, M., Sue, C. (2013). Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology, 81(21), 1819-1826. [More Information]
  • Woodbridge, P., Liang, C., Davis, R., Vandebona, H., Sue, C. (2013). POLG mutations in Australian patients with mitochondrial disease. Internal Medicine Journal, 43(2), 150-156. [More Information]
  • Davis, R., Sue, C. (2011). The genetics of mitochondrial disease. Seminars in Neurology, 31(5), 519-530. [More Information]

2013

  • Davis, R., Liang, C., Edema-Hildebrand, F., Riley, C., Needham, M., Sue, C. (2013). Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology, 81(21), 1819-1826. [More Information]
  • Woodbridge, P., Liang, C., Davis, R., Vandebona, H., Sue, C. (2013). POLG mutations in Australian patients with mitochondrial disease. Internal Medicine Journal, 43(2), 150-156. [More Information]

2011

  • Davis, R., Sue, C. (2011). The genetics of mitochondrial disease. Seminars in Neurology, 31(5), 519-530. [More Information]

To update your profile click here. For support on your academic profile contact .